Former Fred Hutch, SCCA board chair was 'a rock of wisdom and stability' during pivotal times
Feb. 23, 2018
| By Mary Engel / Fred Hutch News Service
The former long-time member and chair of the Fred Hutch Board of Trustees, Shan Mullin was 'a rock of wisdom and stability' during pivotal times that included the founding of Seattle Cancer Care Alliance.
Physician-scientist led the charge in prioritizing fundamental research, built bridges between lab and clinic
Oct. 12, 2017
| By Rachel Tompa / Fred Hutch News Service
Dr. Paul Neiman, a founding member of Fred Hutchinson Cancer Research Center and a transplant physician and cancer biologist, died Oct. 11 of complications from pancreatic cancer. He was 78. Neiman was also one of the founders and leaders of the Basic Sciences Division, one of the Hutch’s five scientific divisions, as well as the division that would later became the Human Biology Division. He served as director of Basic Sciences from 1983 to 1995. He retired from Fred Hutch in 2010.
New research writes latest chapter in one drug's story
June 27, 2017
| by Susan Keown / Fred Hutch News Service
The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Dec. 16, 2016
| By Susan Keown / Fred Hutch News Service
Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.